406 related articles for article (PubMed ID: 2944621)
1. Indomethacin therapy abrogates the prostaglandin-mediated suppression of natural killer activity in tumor-bearing mice and prevents tumor metastasis.
Lala PK; Parhar RS; Singh P
Cell Immunol; 1986 Apr; 99(1):108-18. PubMed ID: 2944621
[TBL] [Abstract][Full Text] [Related]
2. Prostaglandin E2-mediated inactivation of various killer lineage cells by tumor-bearing host macrophages.
Parhar RS; Lala PK
J Leukoc Biol; 1988 Dec; 44(6):474-84. PubMed ID: 2973508
[TBL] [Abstract][Full Text] [Related]
3. Immunotherapy of mammary adenocarcinoma metastases in C3H/HeN mice with chronic administration of cyclo-oxygenase inhibitors alone or in combination with IL-2.
Khoo NK; Chan FP; Saarloos MN; Lala PK
Clin Exp Metastasis; 1992 Jul; 10(4):239-52. PubMed ID: 1617832
[TBL] [Abstract][Full Text] [Related]
4. Changes in the host natural killer cell population in mice during tumor development. 2. The mechanism of suppression of NK activity.
Parhar RS; Lala PK
Cell Immunol; 1985 Jul; 93(2):265-79. PubMed ID: 3159480
[TBL] [Abstract][Full Text] [Related]
5. Prostaglandin-mediated inactivation of natural killer cells in the murine decidua.
Scodras JM; Parhar RS; Kennedy TG; Lala PK
Cell Immunol; 1990 May; 127(2):352-67. PubMed ID: 2139365
[TBL] [Abstract][Full Text] [Related]
6. Differential induction of suppressor macrophages by cloned Lewis lung carcinoma variants in mice.
Young MR; Newby M
J Natl Cancer Inst; 1986 Dec; 77(6):1255-60. PubMed ID: 3491925
[TBL] [Abstract][Full Text] [Related]
7. Changes in the host natural killer cell population in mice during tumor development. 1. Kinetics and in vivo significance.
Lala PK; Santer V; Libenson H; Parhar RS
Cell Immunol; 1985 Jul; 93(2):250-64. PubMed ID: 4005957
[TBL] [Abstract][Full Text] [Related]
8. Macrophage-mediated suppression of natural killer cell activity in mice bearing Lewis lung carcinoma.
Young MR; Wheeler E; Newby M
J Natl Cancer Inst; 1986 Apr; 76(4):745-50. PubMed ID: 3457207
[TBL] [Abstract][Full Text] [Related]
9. Differential sensitivity of metastatic versus nonmetastatic mammary tumor cells to macrophage-mediated cytostasis.
Yamashina K; Fulton A; Heppner G
J Natl Cancer Inst; 1985 Oct; 75(4):765-70. PubMed ID: 3862907
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of experimental metastasis with indomethacin: role of macrophages and natural killer cells.
Fulton AM
Prostaglandins; 1988 Mar; 35(3):413-25. PubMed ID: 3163812
[TBL] [Abstract][Full Text] [Related]
11. Effects of histamine type-2 receptor antagonists on indomethacin and IL-2 immunotherapy of metastasis.
Saarloos MN; Khoo NK; Lala PK
Clin Exp Metastasis; 1993 May; 11(3):275-83. PubMed ID: 8097142
[TBL] [Abstract][Full Text] [Related]
12. Amelioration of B16F10 melanoma lung metastasis in mice by a combination therapy with indomethacin and interleukin 2.
Parhar RS; Lala PK
J Exp Med; 1987 Jan; 165(1):14-28. PubMed ID: 3491867
[TBL] [Abstract][Full Text] [Related]
13. Stimulation of natural killer cell numbers but not function in leukemic infant mice: a system primed in infancy allows survival in adulthood.
Dussault I; Miller SC
Nat Immun; 1993; 12(2):66-78. PubMed ID: 8318817
[TBL] [Abstract][Full Text] [Related]
14. The modulation of human natural killer cell activity by prostaglandins.
Bankhurst AD
J Clin Lab Immunol; 1982 Feb; 7(2):85-91. PubMed ID: 6951051
[TBL] [Abstract][Full Text] [Related]
15. Induction of natural killer cell activity in mice by injection of indomethacin.
Voth R; Chmielarczyk W; Storch E; Kirchner H
Nat Immun Cell Growth Regul; 1986; 5(6):317-24. PubMed ID: 2432415
[TBL] [Abstract][Full Text] [Related]
16. Cure of human melanoma lung metastases in nude mice with chronic indomethacin therapy combined with multiple rounds of IL-2: characteristics of killer cells generated in situ.
Lala PK; Elkashab M; Kerbel RS; Parhar RS
Int Immunol; 1990; 2(12):1149-58. PubMed ID: 2090199
[TBL] [Abstract][Full Text] [Related]
17. Activation of maternal killer cells in the pregnant uterus with chronic indomethacin therapy, IL-2 therapy, or a combination therapy is associated with embryonic demise.
Lala PK; Scodras JM; Graham CH; Lysiak JJ; Parhar RS
Cell Immunol; 1990 May; 127(2):368-81. PubMed ID: 2328531
[TBL] [Abstract][Full Text] [Related]
18. Rapid killing of actinomycin D-treated tumor cells by human mononuclear cells. I. Effectors belong to the monocyte-macrophage lineage.
Colotta F; Peri G; Villa A; Mantovani A
J Immunol; 1984 Feb; 132(2):936-44. PubMed ID: 6690624
[TBL] [Abstract][Full Text] [Related]
19. Splenic natural cytotoxic activity is enhanced during growth of a murine fibrosarcoma.
MacIntyre JP; Hoskin DW; Pope BL
Immunobiology; 1990 Feb; 180(2-3):243-60. PubMed ID: 2345016
[TBL] [Abstract][Full Text] [Related]
20. Activation of natural killer-derived cytotoxic T lymphocytes. I. Regulation by macrophage and prostaglandins.
Ting CC; Hargrove ME
J Immunol; 1983 Oct; 131(4):1734-41. PubMed ID: 6604751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
